Register by Friday, February 23 to Save Up to $350!
Uniting Large Pharma, Innovative Biotech & Leading Academics Dedicated to Accelerating Precision Medicine Therapies to Patients in Need
The industry has made unequivocal advances, from tangible progress using artificial intelligence to robust biomarker development, permitting precise prognosis, astute stratification, and meticulous patient monitoring. Unsurprisingly, this is reflected by countless recent approvals, IND filings, and new companies emerging out of stealth-mode.
The Precision Medicine in Inflammatory Bowel Disease Summit is returning for the second year, as the most comprehensive, ultra-specialized meeting uniting experts to explore developments that will fast-track the optimization of drug development and overcome the one-size-fits-all approach to medicine.
What’s New for 2024?
Streamline your pipeline with fresh insights from a brand-new speaker faculty, including thought leaders from Bristol Myers Squibb, Takeda, Merck, Seres Therapeutics, Palatin Technologies, Alumis, and many more.
With new speakers comes new data: gain actionable insights on novel strategies, exciting developments and future perspectives to fast-track development in your field!
2024 Expert Speakers Include
Vice President & Gastroenterology Disease Area Stronghold Lead, Immunology
Janssen Pharmaceuticals, Johnson & Johnson
Vice President, Genetics & Precision Immunology
Principal Scientist, Translational Biomarker Lead, GI Drug Discovery
Attending Companies Include
“This meeting presents a great opportunity to connect with others in the Precision Medicine field to share ideas and ways in which to better benefit patients”
Past Attendee, Scientific Director, Precision Medicine & Immunology, AbbVie
“This meeting provides a great opportunity to strengthen the case for precision medicine in IBD which will be hugely beneficial for patients.”